Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | Pirotinib |
Synonyms | |
Therapy Description |
Pirotinib (KBP-5209) inhibits EGFR, ERBB2 (HER2), and ERBB4 (HER4), potentially resulting in decreased tumor growth (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Pirotinib | KBP-5209|KBP5209 | HER inhibitor (Pan) 6 | Pirotinib (KBP-5209) inhibits EGFR, ERBB2 (HER2), and ERBB4 (HER4), potentially resulting in decreased tumor growth (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02442414 | Phase I | Pirotinib | A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors | Completed | USA | 0 |